Head-to-head: Etoposide and irinotecan equally effective in neuroendocrine carcinoma Presented ByDr Chigusa Morizane, National Cancer Center Hospital, Japan TrialPhase 3, JCOG1213, TOPIC-NEC ConferenceASCO GI 2022 21 March, 2022 12:26